Selected research
Market Structure
Global Nicotinamide Riboside (NR) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Nicotinamide Riboside (NR) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Bontac, Tiantai Biotechnology, Zhejiang Jiahua, Shandong Tianming Pharmaceutical, Suzhou MyLand Pharm & Nutrition, EnzymeWorks and Longer Livetech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Nicotinamide Riboside (NR) output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Nicotinamide Riboside (NR) by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Nicotinamide Riboside (NR) market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nicotinamide Riboside (NR) and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nicotinamide Riboside (NR) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Riboside (NR) market size, projected growth trends, production technologies, key applications, and end-use industries.
Nicotinamide Riboside (NR) Segment by Company
ChromaDex
Genex Formulas
Bontac
Tiantai Biotechnology
Zhejiang Jiahua
Shandong Tianming Pharmaceutical
Suzhou MyLand Pharm & Nutrition
EnzymeWorks
Longer Livetech
Shenzhen Ejion Biotechnology
Nicotinamide Riboside (NR) Segment by Type
Purity ≤98%
Purity >98%
Nicotinamide Riboside (NR) Segment by Application
Health Supplement
Pharmaceutical Additives
Nicotinamide Riboside (NR) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Nicotinamide Riboside (NR) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Riboside (NR) industry.
Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) market competition landscape. Including Nicotinamide Riboside (NR) manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Nicotinamide Riboside (NR) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Nicotinamide Riboside (NR) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≤98%
- Purity >98%
Applications
- Health Supplement
- Pharmaceutical Additives
Companies covered
- ChromaDex
- Genex Formulas
- Bontac
- Tiantai Biotechnology
- Zhejiang Jiahua
- Shandong Tianming Pharmaceutical
- Suzhou MyLand Pharm & Nutrition
- EnzymeWorks
- Longer Livetech
- Shenzhen Ejion Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nicotinamide Riboside (NR) Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Nicotinamide Riboside (NR) Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Nicotinamide Riboside (NR) Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Nicotinamide Riboside (NR) Market Dynamics
- 2.1 Nicotinamide Riboside (NR) Industry Trends
- 2.2 Nicotinamide Riboside (NR) Industry Drivers
- 2.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
- 2.4 Nicotinamide Riboside (NR) Industry Restraints
3 Nicotinamide Riboside (NR) Market by Manufacturers
- 3.1 Global Nicotinamide Riboside (NR) Production Value by Manufacturers (2021-2026)
- 3.2 Global Nicotinamide Riboside (NR) Production by Manufacturers (2021-2026)
- 3.3 Global Nicotinamide Riboside (NR) Average Price by Manufacturers (2021-2026)
- 3.4 Global Nicotinamide Riboside (NR) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nicotinamide Riboside (NR) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Nicotinamide Riboside (NR) Manufacturers, Product Type & Application
- 3.7 Global Nicotinamide Riboside (NR) Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nicotinamide Riboside (NR) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nicotinamide Riboside (NR) Players Market Share by Production Value in 2025
- 3.8.3 2025 Nicotinamide Riboside (NR) Tier 1, Tier 2, and Tier 3
4 Nicotinamide Riboside (NR) Market by Type
- 4.1 Nicotinamide Riboside (NR) Type Introduction
- 4.1.1 Purity ≤98%
- 4.1.2 Purity >98%
- 4.2 Global Nicotinamide Riboside (NR) Production by Type
- 4.2.1 Global Nicotinamide Riboside (NR) Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Nicotinamide Riboside (NR) Production by Type (2021-2032)
- 4.2.3 Global Nicotinamide Riboside (NR) Production Market Share by Type (2021-2032)
- 4.3 Global Nicotinamide Riboside (NR) Production Value by Type
- 4.3.1 Global Nicotinamide Riboside (NR) Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Nicotinamide Riboside (NR) Production Value by Type (2021-2032)
- 4.3.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Type (2021-2032)
5 Nicotinamide Riboside (NR) Market by Application
- 5.1 Nicotinamide Riboside (NR) Application Introduction
- 5.1.1 Health Supplement
- 5.1.2 Pharmaceutical Additives
- 5.2 Global Nicotinamide Riboside (NR) Production by Application
- 5.2.1 Global Nicotinamide Riboside (NR) Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Nicotinamide Riboside (NR) Production by Application (2021-2032)
- 5.2.3 Global Nicotinamide Riboside (NR) Production Market Share by Application (2021-2032)
- 5.3 Global Nicotinamide Riboside (NR) Production Value by Application
- 5.3.1 Global Nicotinamide Riboside (NR) Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Nicotinamide Riboside (NR) Production Value by Application (2021-2032)
- 5.3.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 ChromaDex
- 6.1.1 ChromaDex Company Information
- 6.1.2 ChromaDex Business Overview
- 6.1.3 ChromaDex Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.1.4 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
- 6.1.5 ChromaDex Recent Developments
- 6.2 Genex Formulas
- 6.2.1 Genex Formulas Company Information
- 6.2.2 Genex Formulas Business Overview
- 6.2.3 Genex Formulas Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
- 6.2.5 Genex Formulas Recent Developments
- 6.3 Bontac
- 6.3.1 Bontac Company Information
- 6.3.2 Bontac Business Overview
- 6.3.3 Bontac Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.3.4 Bontac Nicotinamide Riboside (NR) Product Portfolio
- 6.3.5 Bontac Recent Developments
- 6.4 Tiantai Biotechnology
- 6.4.1 Tiantai Biotechnology Company Information
- 6.4.2 Tiantai Biotechnology Business Overview
- 6.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.4.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
- 6.4.5 Tiantai Biotechnology Recent Developments
- 6.5 Zhejiang Jiahua
- 6.5.1 Zhejiang Jiahua Company Information
- 6.5.2 Zhejiang Jiahua Business Overview
- 6.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.5.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
- 6.5.5 Zhejiang Jiahua Recent Developments
- 6.6 Shandong Tianming Pharmaceutical
- 6.6.1 Shandong Tianming Pharmaceutical Company Information
- 6.6.2 Shandong Tianming Pharmaceutical Business Overview
- 6.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.6.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
- 6.6.5 Shandong Tianming Pharmaceutical Recent Developments
- 6.7 Suzhou MyLand Pharm & Nutrition
- 6.7.1 Suzhou MyLand Pharm & Nutrition Company Information
- 6.7.2 Suzhou MyLand Pharm & Nutrition Business Overview
- 6.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.7.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
- 6.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
- 6.8 EnzymeWorks
- 6.8.1 EnzymeWorks Company Information
- 6.8.2 EnzymeWorks Business Overview
- 6.8.3 EnzymeWorks Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.8.4 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
- 6.8.5 EnzymeWorks Recent Developments
- 6.9 Longer Livetech
- 6.9.1 Longer Livetech Company Information
- 6.9.2 Longer Livetech Business Overview
- 6.9.3 Longer Livetech Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.9.4 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
- 6.9.5 Longer Livetech Recent Developments
- 6.10 Shenzhen Ejion Biotechnology
- 6.10.1 Shenzhen Ejion Biotechnology Company Information
- 6.10.2 Shenzhen Ejion Biotechnology Business Overview
- 6.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
- 6.10.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
- 6.10.5 Shenzhen Ejion Biotechnology Recent Developments
7 Global Nicotinamide Riboside (NR) Production by Region
- 7.1 Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Nicotinamide Riboside (NR) Production by Region (2021-2032)
- 7.2.1 Global Nicotinamide Riboside (NR) Production by Region (2021-2026)
- 7.2.2 Global Nicotinamide Riboside (NR) Production Forecast by Region (2027-2032)
- 7.3 Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Nicotinamide Riboside (NR) Production Value by Region (2021-2032)
- 7.4.1 Global Nicotinamide Riboside (NR) Production Value by Region (2021-2026)
- 7.4.2 Global Nicotinamide Riboside (NR) Production Value by Region (2027-2032)
- 7.5 Global Nicotinamide Riboside (NR) Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Nicotinamide Riboside (NR) Production Value (2021-2032)
- 7.6.2 Europe Nicotinamide Riboside (NR) Production Value (2021-2032)
- 7.6.3 Asia-Pacific Nicotinamide Riboside (NR) Production Value (2021-2032)
- 7.6.4 South America Nicotinamide Riboside (NR) Production Value (2021-2032)
- 7.6.5 Middle East & Africa Nicotinamide Riboside (NR) Production Value (2021-2032)
8 Global Nicotinamide Riboside (NR) Consumption by Region
- 8.1 Global Nicotinamide Riboside (NR) Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Nicotinamide Riboside (NR) Consumption by Region (2021-2032)
- 8.2.1 Global Nicotinamide Riboside (NR) Consumption by Region (2021-2026)
- 8.2.2 Global Nicotinamide Riboside (NR) Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Nicotinamide Riboside (NR) Value Chain Analysis
- 9.1.1 Nicotinamide Riboside (NR) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Nicotinamide Riboside (NR) Production Mode & Process
- 9.2 Nicotinamide Riboside (NR) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nicotinamide Riboside (NR) Distributors
- 9.2.3 Nicotinamide Riboside (NR) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst